메뉴 건너뛰기




Volumn 37, Issue 2, 2017, Pages 740-749

Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer's disease

Author keywords

2 deoxy 2 18F fluoro D glucose; Alzheimer's disease; early phase carbon 11 Pittsburgh Compound B; early phase 18F THK5317 positron emission tomography; simplified reference tissue model R 1

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GLUCOSE; PITTSBURGH COMPOUND B; THK 5317 F 18; UNCLASSIFIED DRUG; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; 6-((3-FLUORO-2-HYDROXY)PROPOXY)-2-(4-METHYLAMINOPHENYL)QUINOLINE; ANILINE DERIVATIVE; QUINOLINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; THIAZOLE DERIVATIVE;

EID: 85009865618     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16645593     Document Type: Article
Times cited : (44)

References (41)
  • 2
    • 84881451115 scopus 로고    scopus 로고
    • Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease
    • Okamura N, Furumoto S, Harada R, et al. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease. J Nucl Med 2013; 54: 1420-1427.
    • (2013) J Nucl Med , vol.54 , pp. 1420-1427
    • Okamura, N.1    Furumoto, S.2    Harada, R.3
  • 3
    • 85056068298 scopus 로고    scopus 로고
    • Unidirectional influx and net accumulation of PIB
    • Blomquist G, Engler H, Nordberg A, et al. Unidirectional influx and net accumulation of PIB. Open Neuroimag J 2008; 2: 114-125.
    • (2008) Open Neuroimag J , vol.2 , pp. 114-125
    • Blomquist, G.1    Engler, H.2    Nordberg, A.3
  • 4
    • 84856056762 scopus 로고    scopus 로고
    • The use of PIB-PET as a dual pathological and functional biomarker in AD
    • Forsberg A, Engler H, Blomquist G, et al. The use of PIB-PET as a dual pathological and functional biomarker in AD. Biochim Biophys Acta 2012; 1822: 380-385.
    • (2012) Biochim Biophys Acta , vol.1822 , pp. 380-385
    • Forsberg, A.1    Engler, H.2    Blomquist, G.3
  • 5
    • 79851503085 scopus 로고    scopus 로고
    • Early 11C-PIB frames and 18F-FDG PET measures are comparable: A study validated in a cohort of AD and FTLD patients
    • Rostomian AH, Madison C, Rabinovici GD, et al. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients. J Nucl Med 2011; 52: 173-179.
    • (2011) J Nucl Med , vol.52 , pp. 173-179
    • Rostomian, A.H.1    Madison, C.2    Rabinovici, G.D.3
  • 6
    • 79952803918 scopus 로고    scopus 로고
    • Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B
    • Meyer PT, Hellwig S, Amtage F, et al. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. J Nucl Med 2011; 52: 393-400.
    • (2011) J Nucl Med , vol.52 , pp. 393-400
    • Meyer, P.T.1    Hellwig, S.2    Amtage, F.3
  • 7
    • 84930985951 scopus 로고    scopus 로고
    • Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis
    • Fu L, Liu L, Zhang J, et al. Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis. Eur Radiol 2014; 24: 2800-2809.
    • (2014) Eur Radiol , vol.24 , pp. 2800-2809
    • Fu, L.1    Liu, L.2    Zhang, J.3
  • 8
    • 84947969582 scopus 로고    scopus 로고
    • 11C-PiB PET in amyloid angiopathy-related symptomatic cerebral hemorrage: Potential diagnostic value?
    • 11C-PiB PET in amyloid angiopathy-related symptomatic cerebral hemorrage: potential diagnostic value? PLoS One 2015; 10: e0139926.
    • (2015) PLoS One , vol.10 , pp. e0139926
    • Farid, K.1    Hong, Y.T.2    Aigbirhio, F.L.3
  • 10
    • 0030468875 scopus 로고    scopus 로고
    • Simplified reference tissue model for PET receptor studies
    • Lammertsma AA and Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996; 4(3 Pt 1): 153-158.
    • (1996) Neuroimage , vol.4 , Issue.3 , pp. 153-158
    • Lammertsma, A.A.1    Hume, S.P.2
  • 11
    • 84862529821 scopus 로고    scopus 로고
    • Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: Preliminary studies
    • Hsiao IT, Huang CC, Hsieh CJ, et al. Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies. Eur J Nucl Med Mol Imaging 2012; 39: 613-620.
    • (2012) Eur J Nucl Med Mol Imaging , vol.39 , pp. 613-620
    • Hsiao, I.T.1    Huang, C.C.2    Hsieh, C.J.3
  • 12
    • 84961244487 scopus 로고    scopus 로고
    • Imaging in vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm
    • Chiotis K, Saint-Aubert L, Savitcheva I, et al. Imaging in vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm. Eur J Nucl Med Mol Imaging 2016; 43: 1686-1699.
    • (2016) Eur J Nucl Med Mol Imaging , vol.43 , pp. 1686-1699
    • Chiotis, K.1    Saint-Aubert, L.2    Savitcheva, I.3
  • 13
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease
    • McKhann GM, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984; 34: 939-944.
    • (1984) Neurology , vol.34 , pp. 939-944
    • McKhann, G.M.1    Drachman, D.2    Folstein, M.3
  • 14
    • 4544350756 scopus 로고    scopus 로고
    • Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment
    • Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-246.
    • (2004) J Intern Med , vol.256 , pp. 240-246
    • Winblad, B.1    Palmer, K.2    Kivipelto, M.3
  • 15
    • 0032988610 scopus 로고    scopus 로고
    • Mild cognitive impairment: Clinical characterization and outcome
    • Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
    • (1999) Arch Neurol , vol.56 , pp. 303-308
    • Petersen, R.C.1    Smith, G.E.2    Waring, S.C.3
  • 16
    • 34447322271 scopus 로고    scopus 로고
    • Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria
    • Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-746.
    • (2007) Lancet Neurol , vol.6 , pp. 734-746
    • Dubois, B.1    Feldman, H.H.2    Jacova, C.3
  • 17
    • 10744232413 scopus 로고    scopus 로고
    • Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
    • Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306-319.
    • (2004) Ann Neurol , vol.55 , pp. 306-319
    • Klunk, W.E.1    Engler, H.2    Nordberg, A.3
  • 18
    • 84963945616 scopus 로고    scopus 로고
    • 18F-THK5117 as a PET tracer for assessing tau pathology
    • 18F-THK5117 as a PET tracer for assessing tau pathology. J Nucl Med 2016; 57: 574-581.
    • (2016) J Nucl Med , vol.57 , pp. 574-581
    • Jonasson, M.1    Wall, A.2    Chiotis, K.3
  • 19
    • 84959912123 scopus 로고    scopus 로고
    • Preclinical evaluation of [F]THK-5105 enantiomers: Effects of chir-ality on its effectiveness as a tau imaging radiotracer
    • Tago T, Furumoto S, Okamura N, et al. Preclinical evaluation of [F]THK-5105 enantiomers: effects of chir-ality on its effectiveness as a tau imaging radiotracer. Mol Imaging Biol 2016; 18: 258-266.
    • (2016) Mol Imaging Biol , vol.18 , pp. 258-266
    • Tago, T.1    Furumoto, S.2    Okamura, N.3
  • 20
    • 84938996337 scopus 로고    scopus 로고
    • [(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease
    • Harada R, Okamura N, Furumoto S, et al. [(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease. Eur J Nucl Med Mol Imaging 2015; 42: 1052-1061.
    • (2015) Eur J Nucl Med Mol Imaging , vol.42 , pp. 1052-1061
    • Harada, R.1    Okamura, N.2    Furumoto, S.3
  • 21
    • 0041569918 scopus 로고    scopus 로고
    • Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe
    • Hammers A, Allom R, Koepp MJ, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp 2003; 19: 224-247.
    • (2003) Hum Brain Mapp , vol.19 , pp. 224-247
    • Hammers, A.1    Allom, R.2    Koepp, M.J.3
  • 22
    • 84873655842 scopus 로고    scopus 로고
    • A European multi-centre PET study of fibrillar amyloid in Alzheimer's disease
    • Nordberg A, Carter SF, Rinne J, et al. A European multi-centre PET study of fibrillar amyloid in Alzheimer's disease. Eur J Nucl Med Mol Imaging 2013; 40: 104-114.
    • (2013) Eur J Nucl Med Mol Imaging , vol.40 , pp. 104-114
    • Nordberg, A.1    Carter, S.F.2    Rinne, J.3
  • 23
    • 33751111992 scopus 로고    scopus 로고
    • Biological parametric mapping: A statistical toolbox for multimodality brain image analysis
    • Casanova R. Biological parametric mapping: a statistical toolbox for multimodality brain image analysis. Neuroimage 2007; 34: 137-143.
    • (2007) Neuroimage , vol.34 , pp. 137-143
    • Casanova, R.1
  • 24
    • 79952709519 scopus 로고    scopus 로고
    • PROC: An open-source package for R and S+ to analyze and compare ROC curves
    • Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform 2011; 12: 1-8.
    • (2011) BMC Bioinform , vol.12 , pp. 1-8
    • Robin, X.1    Turck, N.2    Hainard, A.3
  • 25
    • 84926443676 scopus 로고    scopus 로고
    • Cocor: A comprehensive solution for the statistical comparison of correlations
    • Diedenhofen B and Musch J. cocor: a comprehensive solution for the statistical comparison of correlations. PLoS One 2015; 10: e0121945.
    • (2015) PLoS One , vol.10 , pp. e0121945
    • Diedenhofen, B.1    Musch, J.2
  • 26
    • 0020964377 scopus 로고
    • Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease
    • de Leon MJ, Ferris SH, George AE, et al. Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease. J Cereb Blood Flow Metab 1983; 3: 391-394.
    • (1983) J Cereb Blood Flow Metab , vol.3 , pp. 391-394
    • De Leon, M.J.1    Ferris, S.H.2    George, A.E.3
  • 27
    • 0021923110 scopus 로고
    • Pathological and positron emission tomographic correlations in Alzheimer's disease
    • Friedland RP, Brun A and Budinger TF. Pathological and positron emission tomographic correlations in Alzheimer's disease. Lancet 1985; 1: 228.
    • (1985) Lancet , vol.1 , pp. 228
    • Friedland, R.P.1    Brun, A.2    Budinger, T.F.3
  • 28
    • 0028280849 scopus 로고
    • The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: A population-based study
    • Claus JJ, van Harskamp F, Breteler MM, et al. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study. Neurology 1994; 44(3 Pt 1): 454-461.
    • (1994) Neurology , vol.44 , Issue.3 , pp. 454-461
    • Claus, J.J.1    Van Harskamp, F.2    Breteler, M.M.3
  • 29
    • 77954560273 scopus 로고    scopus 로고
    • Arterial spin labeling blood flow MRI: Its role in the early characterization of Alzheimer's disease
    • Alsop DC, Dai W, Grossman M, et al. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J Alzheimers Dis 2010; 20: 871-880.
    • (2010) J Alzheimers Dis , vol.20 , pp. 871-880
    • Alsop, D.C.1    Dai, W.2    Grossman, M.3
  • 30
    • 0345161819 scopus 로고    scopus 로고
    • Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease
    • Backman L, Andersson JL, Nyberg L, et al. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology 1999; 52: 1861-1870.
    • (1999) Neurology , vol.52 , pp. 1861-1870
    • Backman, L.1    Andersson, J.L.2    Nyberg, L.3
  • 31
    • 0024561561 scopus 로고
    • Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain
    • Yamaguchi H, Hirai S, Morimatsu M, et al. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain. Acta Neuropathol 1989; 77: 314-319.
    • (1989) Acta Neuropathol , vol.77 , pp. 314-319
    • Yamaguchi, H.1    Hirai, S.2    Morimatsu, M.3
  • 32
    • 0028347949 scopus 로고
    • Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: A study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
    • Mirra SS, Gearing M, McKeel DW Jr, et al. Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). J Neuropathol Exp Neurol 1994; 53: 303-315.
    • (1994) J Neuropathol Exp Neurol , vol.53 , pp. 303-315
    • Mirra, S.S.1    Gearing, M.2    McKeel, D.W.3
  • 33
    • 0029094457 scopus 로고
    • Preserved pon-tine glucose metabolism in Alzheimer disease: A reference region for functional brain image (PET) analysis
    • Minoshima S, Frey KA, Foster NL, et al. Preserved pon-tine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 1995; 19: 541-547.
    • (1995) J Comput Assist Tomogr , vol.19 , pp. 541-547
    • Minoshima, S.1    Frey, K.A.2    Foster, N.L.3
  • 34
    • 0036743220 scopus 로고    scopus 로고
    • Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
    • Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002; 17: 302-316.
    • (2002) Neuroimage , vol.17 , pp. 302-316
    • Herholz, K.1    Salmon, E.2    Perani, D.3
  • 35
    • 0028341567 scopus 로고
    • Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia
    • Talbot PR, Lloyd JJ, Snowden JS, et al. Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur J Nucl Med 1994; 21: 503-508.
    • (1994) Eur J Nucl Med , vol.21 , pp. 503-508
    • Talbot, P.R.1    Lloyd, J.J.2    Snowden, J.S.3
  • 36
    • 0033606144 scopus 로고    scopus 로고
    • Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type
    • Pickut BA, Dierckx RA, Dobbeleir A, et al. Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type. Psychiatry Res 1999; 90: 103-112.
    • (1999) Psychiatry Res , vol.90 , pp. 103-112
    • Pickut, B.A.1    Dierckx, R.A.2    Dobbeleir, A.3
  • 37
    • 84941426553 scopus 로고    scopus 로고
    • Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: Two sides of the same coin?
    • Verfaillie SC, Adriaanse SM, Binnewijzend MA, et al. Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin? Eur Radiol 2015; 25: 3050-3059.
    • (2015) Eur Radiol , vol.25 , pp. 3050-3059
    • Verfaillie, S.C.1    Adriaanse, S.M.2    Ma, B.3
  • 38
    • 84875350349 scopus 로고    scopus 로고
    • Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner
    • Huisman MC, van Golen LW, Hoetjes NJ, et al. Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner. EJNMMI Res 2012; 2: 1-9.
    • (2012) EJNMMI Res , vol.2 , pp. 1-9
    • Huisman, M.C.1    Van Golen, L.W.2    Hoetjes, N.J.3
  • 40
    • 84895825026 scopus 로고    scopus 로고
    • Blood-brain transfer of Pittsburgh compound B in humans
    • Gjedde A, Aanerud J, Braendgaard H, et al. Blood-brain transfer of Pittsburgh compound B in humans. Front Aging Neurosci 2013; 5: 1-9.
    • (2013) Front Aging Neurosci , vol.5 , pp. 1-9
    • Gjedde, A.1    Aanerud, J.2    Braendgaard, H.3
  • 41
    • 85017364549 scopus 로고    scopus 로고
    • (1)(8)F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
    • Smailagic N, Vacante M, Hyde C, et al. (1)(8)F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2015; 1: CD010632.
    • (2015) Cochrane Database Syst Rev , vol.1 , pp. CD010632
    • Smailagic, N.1    Vacante, M.2    Hyde, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.